Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/toxins14070443
PubMed Identifier: 35878181
Publication URI: http://europepmc.org/abstract/MED/35878181
Type: Journal Article/Review
Parent Publication: Toxins
Issue: 7
ISSN: 2072-6651